Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Vancomycin-induced linear IgA dermatosis].

Thomas Brinkmeier1, Bernd Angelkort, Peter J Frosch

  • 1Hautklinik, Klinikum Dortmund gGmbH und Universität Witten/Herdecke. t.brinkmeier@derma.de

Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG
|November 16, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG·2021
Same author

Metastatic pigmented epithelioid melanocytoma in a 7-year-old female.

Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG·2021
Same author

Lipase elevation and type 1 diabetes mellitus related to immune checkpoint inhibitor therapy - A multicentre study of 90 patients from the German Dermatooncology Group.

European journal of cancer (Oxford, England : 1990)·2021
Same author

Retrospective Analysis of Checkpoint Inhibitor Therapy-Associated Cases of Bullous Pemphigoid From Six German Dermatology Centers.

Frontiers in immunology·2021
Same author

ESSCA results with nickel, cobalt and chromium, 2009-2012.

Contact dermatitis·2016
Same author

Immune checkpoint blockade with concurrent electrochemotherapy in advanced melanoma: a retrospective multicenter analysis.

Cancer immunology, immunotherapy : CII·2016

Linear IgA disease, a rare autoimmune skin disorder, can be triggered by medications like vancomycin. Prompt diagnosis and drug withdrawal lead to rapid patient recovery.

Area of Science:

  • Dermatology
  • Autoimmunology
  • Pharmacology

Background:

  • Linear IgA disease is a rare autoimmune bullous disorder with unclear pathogenic mechanisms.
  • Its clinical presentation is highly variable, making diagnosis challenging.
  • Identifying the etiology, whether idiopathic or drug-induced, is critical for management.

Observation:

  • Frozen section biopsies are valuable for differentiating linear IgA disease from other blistering disorders.
  • Vancomycin is a frequently implicated drug in drug-induced linear IgA disease.
  • Associations with malignancy or other autoimmune conditions require further investigation.

Findings:

  • This case highlights vancomycin-induced linear IgA disease.
  • Immediate vancomycin discontinuation resulted in cessation of blister formation within 24 hours.

Related Experiment Videos

  • Complete skin healing occurred within two weeks of drug withdrawal.

    • Implications:

    • Early recognition and withdrawal of offending agents like vancomycin are crucial for managing drug-induced linear IgA disease.
    • This case underscores the importance of reviewing medication history in patients presenting with blistering disorders.
    • Prompt histopathological examination aids in rapid diagnosis and guides treatment decisions.